Advertisement
Canada markets close in 4 hours 41 minutes

  • S&P/TSX

    21,754.21
    -119.51 (-0.55%)
     

  • S&P 500

    5,003.18
    -68.45 (-1.35%)
     

  • DOW

    37,828.27
    -632.65 (-1.64%)
     

  • CAD/USD

    0.7297
    -0.0001 (-0.01%)
     

  • CRUDE OIL

    82.39
    -0.42 (-0.51%)
     

  • Bitcoin CAD

    86,955.50
    -2,205.84 (-2.47%)
     

  • CMC Crypto 200

    1,373.02
    -9.55 (-0.69%)
     

  • GOLD FUTURES

    2,346.90
    +8.50 (+0.36%)
     

  • RUSSELL 2000

    1,967.63
    -27.80 (-1.39%)
     

  • 10-Yr Bond

    4.7100
    +0.0580 (+1.25%)
     

  • NASDAQ

    15,430.87
    -281.88 (-1.79%)
     

  • VOLATILITY

    16.99
    +1.02 (+6.38%)
     

  • FTSE

    8,070.35
    +29.97 (+0.37%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6808
    -0.0011 (-0.16%)
     
BREAKING:

HONDA TO SET UP $15B EV PRODUCTION BASE IN CANADA

Automaker to get up to $5B in government assistance for EV battery, assembly plants

Allergan, Adamas settle patent lawsuit with Amneal

Reuters
Traders work at the post where Allergan stock is traded on the floor of the New York Stock Exchange (NYSE) April 6, 2016. REUTERS/Brendan McDermid - RTSDV88 (Reuters)

(Reuters) - Allergan Plc said it and Adamas Pharmaceuticals Inc settled a patent infringement lawsuit with Amneal Pharmaceuticals over their Alzheimer's drug.

Allergan said its Forest Labs unit and Adamas had filed a lawsuit against privately owned Amneal, which was seeking regulatory approval for generic versions of Namzaric.

The drug, which has been licensed to Forest by Adamas, had U.S. sales of $12.8 million for the quarter ended June 30.

Under the settlement terms, Forest and Adamas will grant Amneal a license to market generic versions of Namzaric from January 1, 2025.

Other terms of the settlement were not disclosed.

Allergan and Adamas have also sued Amerigen Pharmaceuticals, which seeks to market generic versions of the drug.

(Reporting by Shailesh Kuber; Editing by Anil D'Silva)